Hematology Transfusion and Cell Therapy

Scope & Guideline

Advancing knowledge in hematology and cell therapy.

Introduction

Explore the comprehensive scope of Hematology Transfusion and Cell Therapy through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Hematology Transfusion and Cell Therapy in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2531-1379
PublisherELSEVIER
Support Open AccessYes
CountryBrazil
TypeJournal
Convergefrom 2018 to 2024
AbbreviationHEMATOL TRANSF CELL / Hematol. Transf. Cell Ther.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal 'Hematology Transfusion and Cell Therapy' focuses on advancing the understanding and treatment of hematological disorders and transfusion medicine. It aims to publish high-quality research that contributes to the clinical practice and scientific knowledge in these fields.
  1. Hematological Disorders:
    The journal covers a wide range of hematological conditions, including leukemias, lymphomas, myelomas, and other blood disorders, emphasizing both clinical and laboratory research.
  2. Transfusion Medicine:
    Research related to blood transfusion practices, safety, and efficacy, including studies on blood components, transfusion reactions, and management protocols.
  3. Cell Therapy and Stem Cell Transplantation:
    Focus on advancements in cell therapies, including hematopoietic stem cell transplantation techniques, outcomes, and challenges, particularly in resource-limited settings.
  4. Infectious Complications in Hematology:
    Exploration of infectious risks associated with hematological diseases and treatments, particularly in the context of COVID-19 and other emerging infections.
  5. Genetic and Molecular Studies:
    Research investigating genetic factors influencing hematological diseases, including molecular diagnostics, biomarkers for disease prognosis, and treatment responses.
  6. Patient Management and Quality of Life:
    Studies addressing patient care strategies, including management of symptoms, side effects of treatments, and overall patient quality of life in hematological settings.
Recent publications indicate emerging themes and trends that reflect the evolving landscape of hematology, transfusion medicine, and cell therapy. These trends highlight the journal's responsiveness to current challenges and advancements in the field.
  1. Impact of COVID-19 on Hematology:
    A significant increase in research addressing the effects of COVID-19 on patients with hematological conditions, including complications, treatment adaptations, and vaccination responses.
  2. Personalized Medicine and Targeted Therapies:
    Growing emphasis on studies exploring personalized treatment approaches in hematology, particularly the use of genetic markers for tailoring therapies.
  3. Patient Blood Management Strategies:
    Emerging focus on optimizing blood use in clinical settings, including protocols for minimizing transfusions and improving patient outcomes.
  4. Innovations in Cell Therapy:
    Increased interest in novel cell therapies, including CAR-T cell therapy and other advanced therapeutic modalities targeting hematological malignancies.
  5. Health Equity and Access to Care:
    Research highlighting disparities in healthcare access and outcomes for hematology patients, particularly in low- and middle-income countries.
  6. Quality of Life Assessments:
    Growing trend towards evaluating the quality of life and psychosocial impacts of hematological diseases and treatments, reflecting a holistic approach to patient care.

Declining or Waning

While the journal continues to explore a wide range of topics, some areas have shown a decline in publication frequency or emphasis over recent years. This may reflect shifts in research focus or advancements in other areas.
  1. Traditional Hematology Techniques:
    There is a noticeable decrease in studies focusing solely on traditional hematological laboratory techniques, as advancements in molecular and genetic diagnostics gain prominence.
  2. Basic Science Research:
    Research that does not directly translate to clinical application is becoming less frequent, as the journal emphasizes studies with immediate clinical relevance.
  3. Historical Perspectives on Hematology:
    Papers focusing on historical analyses or reviews of past practices in hematology are becoming less common, reflecting a shift towards contemporary issues and innovations.

Similar Journals

Transfusionsmedizin

Uniting expertise to improve blood transfusion safety and efficacy.
Publisher: GEORG THIEME VERLAG KGISSN: 2191-8805Frequency: 4 issues/year

Transfusionsmedizin is a premier journal dedicated to the field of transfusion medicine, published by the renowned GEORG THIEME VERLAG KG. With an ISSN of 2191-8805 and an E-ISSN of 2191-8813, this journal serves as a vital platform for disseminating cutting-edge research and clinical advancements in blood transfusion practices. Although it operates under a subscription model, the journal is committed to high-quality peer-reviewed content that addresses contemporary challenges and innovations in transfusion therapy. By fostering dialogue among researchers, clinicians, and students, Transfusionsmedizin aims to advance patient care and enhance the safety and efficacy of transfusion practices globally. Its contributions are essential for professionals engaged in transfusion science, hematology, and related medical fields, solidifying its reputation as a critical resource for staying abreast of the latest developments in transfusion research.

BLOOD REVIEWS

Pioneering insights into blood health and disease.
Publisher: CHURCHILL LIVINGSTONEISSN: 0268-960XFrequency: 6 issues/year

BLOOD REVIEWS is a highly regarded journal published by Churchill Livingstone, specializing in the fields of Hematology and Oncology. With an impressive Q1 ranking in both disciplines and placing in the top 10% of its peer categories according to Scopus metrics, it provides an essential platform for the dissemination of cutting-edge research and reviews pertaining to blood disorders and cancer treatment. Since its inception in 1987 and continuing through 2024, the journal has established itself as a cornerstone for healthcare professionals, researchers, and students who seek to advance their understanding of hematologic and oncologic topics. While not an open-access journal, BLOOD REVIEWS retains a reputation for delivering high-quality, peer-reviewed articles that foster dialogue and innovation within the scientific community. For those in the United States and beyond, the journal serves as a vital resource, housed at the Journal Production Department in Edinburgh, Scotland, ensuring accessibility and a global reach in its critical academic contributions.

Asian Journal of Transfusion Science

Empowering research in hematology and immunology.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0973-6247Frequency: 2 issues/year

Asian Journal of Transfusion Science, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, is a prominent open-access journal dedicated to the interdisciplinary fields of hematology and immunology. With an ISSN of 0973-6247 and E-ISSN 1998-3565, it serves as a crucial platform for researchers, clinicians, and students from around the globe, facilitating the dissemination of high-quality, peer-reviewed research. Established in 2007, the journal has consistently aimed to advance scientific knowledge in transfusion practices, enhancing patient care and safety in transfusion medicine. Despite its recent categorization in the Q4 quartile within both Hematology and Immunology, the journal is making strides toward greater visibility in the academic community, with plans for expanded reach and increased citation impact. With its commitment to open-access publishing, the Asian Journal of Transfusion Science ensures that invaluable research findings are readily accessible to all stakeholders, thereby bolstering collaborative efforts in transfusion science and related disciplines.

Hematology-American Society of Hematology Education Program

Navigating the Future of Hematology Together
Publisher: AMER SOC HEMATOLOGYISSN: 1520-4391Frequency: 1 issue/year

Hematology-American Society of Hematology Education Program is a premier peer-reviewed journal dedicated to advancing the field of hematology through comprehensive educational content. Published by the American Society of Hematology, this journal plays a crucial role in disseminating knowledge to researchers, clinicians, and students in hematology and related disciplines. With an impressive Q1 status in the field, it ranks among the top journals at the forefront of hematological research, as evidenced by its 60th percentile ranking in Scopus' Medicine - Hematology category. Although it does not offer open access, the journal provides invaluable insights and educational resources from leading experts, focusing on the latest advancements, treatment protocols, and evolving understanding of blood disorders. Covering a wide range of topics, from basic research to clinical applications, this journal is essential for anyone seeking to deepen their expertise and stay informed on the latest developments in hematology. For further engagement, readers can access insightful articles published since 2001, ensuring a rich repository of knowledge for ongoing research and clinical excellence.

CURRENT OPINION IN HEMATOLOGY

Unveiling the latest trends in hematology for professionals.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1065-6251Frequency: 6 issues/year

CURRENT OPINION IN HEMATOLOGY is a leading peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the latest advancements and insights in the field of hematology. With an impressive impact factor and ranked in the first quartile (Q1) of its category, this journal serves as a vital resource for researchers, clinicians, and students seeking to stay informed on contemporary issues and emerging trends in hematological research and treatment. Established in 1994, it showcases critical reviews, expert commentary, and systematic analyses across a broad spectrum of hematology topics, contributing significantly to clinical and experimental knowledge through its robust editorial standards. While offering traditional subscription access, CURRENT OPINION IN HEMATOLOGY remains committed to providing a platform that bridges the gap between fundamental research and clinical application, making it indispensable for professionals dedicated to advancing patient care and scientific understanding in hematology.

TRANSFUSION MEDICINE AND HEMOTHERAPY

Transforming patient care through cutting-edge research.
Publisher: KARGERISSN: 1660-3796Frequency: 6 issues/year

TRANSFUSION MEDICINE AND HEMOTHERAPY, published by KARGER, is a prominent journal dedicated to advancing the fields of hematology and transfusion medicine. With an ISSN of 1660-3796 and E-ISSN 1660-3818, this esteemed journal has been a valuable resource for researchers and clinicians since its inception in 1973, with significant publication phases continuing into 2024. It currently holds a Q2 ranking in Hematology and a Q3 ranking in Immunology and Allergy, reflecting its impact and relevance in these critical fields. The journal features original articles, reviews, and clinical studies, presenting cutting-edge research that aids in the development of effective therapies and enhances patient care. Open access options are available, ensuring that crucial findings are accessible to a broad audience. As an important platform for dialogue and advancement in transfusion science, TRANSFUSION MEDICINE AND HEMOTHERAPY supports the global health community's efforts to improve treatment outcomes and foster innovation in medical practices.

Hematologie

Empowering the Future of Hematological Sciences
Publisher: JOHN LIBBEY EUROTEXT LTDISSN: 1264-7527Frequency: 6 issues/year

Hematologie is a highly regarded journal in the field of hematology, published by JOHN LIBBEY EUROTEXT LTD. With an ISSN of 1264-7527 and an E-ISSN of 1950-6368, this journal has established itself as a vital resource for researchers, clinicians, and students dedicated to advancing the understanding of blood disorders and treatments. Although the journal's coverage in Scopus was discontinued in 2018, it has continually provided invaluable insights and research findings. The journal aims to foster knowledge sharing and discussion in hematology, exploring innovative methodologies and emerging trends in the field. With a commitment to quality research, Hematologie remains an essential platform for disseminating critical findings that can drive clinical practice and influence future studies in hematological sciences.

INTERNATIONAL JOURNAL OF HEMATOLOGY

Unveiling Innovations in Hematology
Publisher: SPRINGER JAPAN KKISSN: 0925-5710Frequency: 12 issues/year

The INTERNATIONAL JOURNAL OF HEMATOLOGY, published by SPRINGER JAPAN KK, serves as a critical platform for advancing research in the field of hematology. With a prestigious history spanning over three decades from 1991 to 2024, this journal is recognized for its impactful contributions, evidenced by its Q2 category ranking in Hematology for 2023, and its notable position at rank #71 out of 137 in the Scopus Medicine Hematology category. Researchers and professionals within the hematology community benefit from the journal's rigorous peer-reviewed articles that cover a wide range of topics, including clinical studies, basic research, and novel therapeutic strategies. Though currently non-open access, it provides essential insights and findings to an audience passionate about the latest advancements in blood disorders and treatments. Situated in Japan, the journal not only showcases high-quality research but also fosters a global exchange of knowledge in hematology, making it a significant resource for scholars, practitioners, and students alike.

Therapeutic Advances in Hematology

Fostering collaboration for a healthier tomorrow.
Publisher: SAGE PUBLICATIONS LTDISSN: 2040-6207Frequency: 1 issue/year

Therapeutic Advances in Hematology is a prestigious, peer-reviewed journal dedicated to advancing the field of hematology through innovative research and clinical studies. Published by SAGE Publications Ltd, this journal has become a vital resource for hematology professionals and researchers since its inception in 2010. With its impactful Q1 ranking in Hematology and a Scopus rank of 62 out of 137, it firmly establishes itself as a leader in disseminating significant findings and therapeutic approaches. The journal has been committed to open access since 2019, ensuring that its cutting-edge research is readily available to the global scientific community. Covering a broad scope of topics within hematology, Therapeutic Advances in Hematology is an essential platform for those seeking to enhance their understanding and implementation of therapeutic practices in hematological conditions. The journal embraces submissions from both clinical and laboratory perspectives, fostering collaboration and dialogue among researchers, clinicians, and students alike.

Blood Transfusion

Connecting Research with Clinical Practice in Hematology.
Publisher: SIMTIPRO SRLISSN: 1723-2007Frequency: 6 issues/year

Blood Transfusion is a leading journal in the fields of Hematology, Immunology, and Medicine, published by SIMTIPRO SRL in Italy. With its ISSN 1723-2007, the journal has established a significant presence in the academic community, as evidenced by its positioning within the Q2 category in Hematology and Medicine (miscellaneous) and Q3 in Immunology and Allergy for 2023. Notably, it ranks #38 out of 137 in the Hematology category, showcasing its impactful contributions to research and practice. Operating under a traditional publishing model, this journal provides valuable insights into advances in blood transfusion science, ultimately aimed at enhancing patient care and outcomes. Spanning from 2003 to 2024, the scope of Blood Transfusion covers a wide range of topics related to hematological and immunological research, making it an essential resource for researchers, healthcare professionals, and students engaged in these critical fields.